Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/86357| Title: | Correction : Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine : pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies |
| Author(s): | Nahas, Stephanie J. Naegel, Steffen Cohen, Joshua M. Ning, Xiaoping Janka, Lindsay Ramirez Campos, Verena Krasenbaum, Lynda J. Holle-Lee, Dagny Kudrow, David Lampl, Christian |
| Issue Date: | 2022 |
| Type: | Article |
| Language: | English |
| URI: | https://opendata.uni-halle.de//handle/1981185920/88310 http://dx.doi.org/10.25673/86357 |
| Open Access: |  Open access publication |
| License: |  (CC BY 4.0) Creative Commons Attribution 4.0 |
| Sponsor/Funder: | Publikationsfonds MLU |
| Journal Title: | The journal of headache and pain |
| Publisher: | Springer Italia |
| Publisher Place: | Milano |
| Volume: | 23 |
| Original Publication: | 10.1186/s10194-022-01423-x |
| Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| s10194-022-01423-x.pdf | 1.11 MB | Adobe PDF |  View/Open |